For research use only. Not for human or veterinary use.
Research Summary
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), comprising the full 44-amino acid sequence of endogenous GHRH with a trans-3-hexenoic acid modification. It is investigated in neuroendocrine and metabolic research for its interactions with GHRH receptors and downstream growth hormone secretion pathways, with particular interest in receptor binding stability and pharmacokinetic studies.
Specifications
|
Tesamorelin |
| CAS |
218949-48-5 |
| Molecular Formula |
C₂₂₁H₃₆₆N₆₈O₆₇S |
| Molecular Weight |
5,135.9 g/mol |
| Purity |
≥99% HPLC verified |
| Form |
Lyophilised powder |
| Available |
2mg / 5mg / 10mg |
Storage & Handling
Store at −20°C, protected from light and moisture. Reconstitute under controlled laboratory conditions using appropriate sterile technique.
Certificate of Analysis
A Certificate of Analysis is available on request for each batch. Contact us to obtain documentation for your records.
Not evaluated by the TGA or any regulatory authority for safety or efficacy in humans or animals.
